Infectolab Americas LLC v. ArminLabs GmbH

Good Law
United States District Court, Northern District of CaliforniaApril 21, 20215:20-cv-03318California3,357 words

Opinion

Trial Court Opinion

UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA SAN JOSE DIVISION 7 INFECTOLAB AMERICAS LLC, et al., Case No. 20-cv-03318-VKD

Plaintiffs,

ORDER GRANTING IN PART AND

v. DENYING IN PART DEFENDANT’S

MOTION TO DISMISS SECOND

ARMINLABS GMBH, AMENDED COMPLAINT Defendant. Re: Dkt. No.

13 I. BACKGROUND Plaintiffs Infectolab Americas LLC (“Infectolab”) and IGeneX, Inc. (“IGeneX”) filed this action alleging violation of the Lanham Act, 41 U.S.C. § 1125(a)(1), and asserting several state law claims for relief. The Court previously granted a Rule 12(b)(6) motion by defendant ArminLabs GmbH (“ArminLabs”) to dismiss three claims asserted only by Infectolab for intentional and negligent interference with prospective economic advantage and tortious interference with contract. Infectolab conceded the motion with respect to its claim for negligent interference with prospective economic advantage, which was dismissed without leave to amend. 22…

Sign in to read the full opinion

Create a free account to read the complete opinion text, citation history, and good-law status for this case.